Abstract
Objectives
Data sources
Review/Analysis methods
Results
Conclusions
- Scholz J.
- Finnerup N.B.
- Attal N.
- Aziz Q.
- Baron R.
- Bennett M.I.
- Benoliel R.
- Cohen M.
- Cruccu G.
- Davis K.D.
- Evers S.
- First M.
- Giamberardino M.A.
- Hansson P.
- Kaasa S.
- Korwisi B.
- Kosek E.
- Lavand'homme P.
- Nicholas M.
- Nurmikko T.
- Perrot S.
- Raja S.N.
- Rice A.S.C.
- Rowbotham M.C.
- Schug S.
- Simpson D.M.
- Smith B.H.
- Svensson P.
- Vlaeyen J.W.S.
- Wang S.J.
- Bark A.
- Rief W.
- Treede R.D.
The IASP classification of chronic pain for ICD-11: Chronic neuropathic pain.
- Schaefer C.
- Mann R.
- Sadosky A.
- Daniel S.
- Parsons B.
- Nieshoff E.
- Tuchman M.
- Nalamachu S.
- Anschel A.
- Stacey B.R.
National Institute for Health and Care Excellence (NICE). (2020). Neuropathic pain in adults: pharmacological management in non-specialist settings clinical guideline [CG173]. Retrieved April 2, 2022, from https://www.nice.org.uk/guidance/cg173/chapter/1-Recommendations .
National Institute for Health and Care Excellence (NICE). (2020). Low back pain and sciatica in over 16s: assessment and management NICE guideline [NG59]. Retrieved April 2, 2022, from https://www.nice.org.uk/guidance/NG59/chapter/Recommendations#non-invasive-treatments-for-low-back-pain-and-sciatica
Methods
- Page M.J.
- McKenzie J.E.
- Bossuyt P.M.
- Boutron I.
- Hoffmann T.C.
- Mulrow C.D.
- Shamseer L.
- Tetzlaff J.M.
- Akl E.A.
- Brennan S.E.
- Chou R.
- Glanville J.
- Grimshaw J.M.
- Hróbjartsson A.
- Lalu M.M.
- Li T.
- Loder E.W.
- Mayo-Wilson E.
- McDonald S.
- McGuinness L.A.
- Stewart L.A.
- Thomas J.
- Tricco A.C.
- Welch V.A.
- Whiting P.
- Moher D.
Eligibility Criteria
Participants
- Scholz J.
- Finnerup N.B.
- Attal N.
- Aziz Q.
- Baron R.
- Bennett M.I.
- Benoliel R.
- Cohen M.
- Cruccu G.
- Davis K.D.
- Evers S.
- First M.
- Giamberardino M.A.
- Hansson P.
- Kaasa S.
- Korwisi B.
- Kosek E.
- Lavand'homme P.
- Nicholas M.
- Nurmikko T.
- Perrot S.
- Raja S.N.
- Rice A.S.C.
- Rowbotham M.C.
- Schug S.
- Simpson D.M.
- Smith B.H.
- Svensson P.
- Vlaeyen J.W.S.
- Wang S.J.
- Bark A.
- Rief W.
- Treede R.D.
The IASP classification of chronic pain for ICD-11: Chronic neuropathic pain.
Interventions
Comparators
Main Outcomes
Additional outcomes
- Dworkin R.H.
- Turk D.C.
- Farrar J.T.
- Haythornthwaite J.A.
- Jensen M.P.
- Katz N.P.
- Kerns R.D.
- Stucki G.
- Allen R.R.
- Bellamy N.
- Carr D.B.
- Chandler J.
- Cowan P.
- Dionne R.
- Galer B.S.
- Hertz S.
- Jadad A.R.
- Kramer L.D.
- Manning D.C.
- Immpact ...
Study design
Search Strategy
Study Selection and Data Extraction
Assessment of Risk of Bias
Data Synthesis
Higgins, J.P.T. & Thomas, J. (Eds.) (2022). Cochrane handbook for systematic reviews of interventions (version 6.3). Retrieved April 2, 2022, from https://training.cochrane.org/handbook/current
I2-values | 0%≤ and ≤30% | >30% and ≤50% | >50% and ≤75% | >75% |
---|---|---|---|---|
Heterogeneity | not important | moderate | substantial | considerable |
Results
Study Selection
- Page M.J.
- McKenzie J.E.
- Bossuyt P.M.
- Boutron I.
- Hoffmann T.C.
- Mulrow C.D.
- Shamseer L.
- Tetzlaff J.M.
- Akl E.A.
- Brennan S.E.
- Chou R.
- Glanville J.
- Grimshaw J.M.
- Hróbjartsson A.
- Lalu M.M.
- Li T.
- Loder E.W.
- Mayo-Wilson E.
- McDonald S.
- McGuinness L.A.
- Stewart L.A.
- Thomas J.
- Tricco A.C.
- Welch V.A.
- Whiting P.
- Moher D.

Study Characteristics
Study ID | Disease (course: T; C) | TCM mind body therapy modality (OTP) | Sample size analysed and drop-off reasons | Treatment group | Control group | Outcome indicators | ||
---|---|---|---|---|---|---|---|---|
Sample size randomized (male-female) / age (M ± SD) | Intervention | Sample size randomized (male-female) / age (M ± SD) | Intervention | |||||
Chen SQ 2014 | LDH (unclear) | Daoyin (导引) (2W) | 60, no drop-off reported | 30 (unclear) / (unclear) | Daoyin: Bid, for 2 weeks | 30 (unclear) / (unclear) | Manipulation: 3 times a week, for 2 weeks | VAS score, JOA score, 3-month follow up (VAS)( |
Feng L 2017 | Cervical spondylotic radiculopathy (3.21 ± 0.93 M/ C1:3.18 ± 1.04 M/ C2:3.32 ± 0.81 M) | Baduanjin (八段锦) (4W) | 134, T: 7-nonadherence, dizziness aggravating; C1: 2-pain aggravating; C3: 6-nonadherence | 50 (26-24) / (45.55 ± 7.33) | Baduanjin, Bid, 20 min each time, for 4 weeks + manipulation, QD, 20 min each time, for 4 weeks | C1: 50 (25-25) / (50.22 ± 4.68) C2: 50 (23-27)/(48.67 ± 6.56) | C1: manipulation, QD, 20 min each time, for 4 weeks C2: manipulation, QD, 20 min each time, for 4 weeks + “米” shaped neck exercise, Bid, 20 min each time, for 4 weeks | Effective rate, VAS score, 3-month follow up (recurrence rate) |
Fu Y 2021 | Sympathetic cervical spondylosis (T: 6.00 ± 9.00M/C: 6.00 ± 9.00M) | Aroma massage (12D) | 86, T: 1-job changing; T: 2-nonadherence, 1-chosed acupuncture | 45 (19-25)/ (31.00 ± 9.50) | Chinese herbs essential oil inhalation and back massage for, QD, 20 min each time, for 12 days | 45 (19-23)/ (31.50 ± 13.75) | Manipulation, QD, 30 min each time, for 12 days | CSSEQ, NRS, NID, effective rate, safety |
Guo H 2020 | Cervical spondylotic radiculopathy (unclear) | One move from Yijinjing (易筋经) (4W, 12W) | 60, no drop off reported | 30 (unclear) / (unclear) | Palm reset Tianmen state, BID, 30 min each time, 6 times a week, for 12 weeks + manipulation, BID, 3 days each week, for 4 weeks | 30 (unclear) / (unclear) | Manipulation, BID, 3 days each week, for 4 weeks | VAS, NDI, cervical physiological curve, computed tomography finite element analysis |
Han BL 2015 | LDH (T1: 3.26 ± 1.03M; T2: 3.35 ± 1.15M/C1: 3.32 ± 1.46M) | Baduanjin (八段锦) (4W) | 60, no drop off reported | T1:20 (10-10) / (51.35 ± 2.65); T2: 20 (12-8) / (50.11 ± 2.15) | T1: Baduanjin, 40 min each time, 5 days each week, for 4 weeks; T2: Baduanjin, 40 min each time, 5 days each week, for 4 weeks + TENS, 30 min each time, 5 days each week, for 4 weeks | 20 (13-7) / (51.82 ± 1.86) | TENS, 30 min each time, 5 days each week, for 4 weeks; | VAS, CODI |
Ji T 2021 | LDH (T: 38.00 ± 18.00W/C: 35.43 ± 12.27W) | Yijinjing (易筋经) (4W) | 60, no drop off reported | 30 (13-17) / (54.27 ± 5.46) | Yijinjing, QD, 45 min each time, for 4 weeks + manipulation, QD, for 4 weeks | 30 (14-16) / (54.87 ± 5.28) | Manipulation, QD, for 4 weeks | VAS, JOA, effective rate |
Li F 2017 | LDH (T1: 1.43 ± 0.24M; T2: 42.65 ± 6.54/C: 1.38 ± 0.52M) | Wuqinxi (五禽戏) (9W) | 90, no drop off reported | T1: 30 (18-12) / (43.57 ± 7.43) T2: 30 (19-11) / (42.65 ± 6.54) | T1: Wuqinxi, QD, 40 min each time, 5 days each week, for 9 weeks; T2: Wuqinxi, QD, 40 min each time, 5 days each week, for 9 weeks + Manipulation, QD, 30-40 min each time, 5 days each week, for 9 weeks; | C1: 30 (17-13) / (44.13 ± 5.13) | Manipulation, QD, 30-40 min each time, 5 days each week, for 9 weeks | VAS, ODI, 5-month follow up (VAS, ODI) |
Li JH 2020 | LDH (T1: 25.9 ± 7.1M; T2: 26.1 ± 7.8M/C: 24.8 ± 6.7M) | Daoyin (导引) (4W) | 120, no drop off reported | T1: 40 (17-23) / (47.9 ± 11.9); T2: 40 (19-21) / (48.7 ± 12.3) | T1: Daoyin for 4 weeks; T2: Daoyin for 4 weeks + manipulation, 3 days each week, for 4 weeks | 40 (18-22) / (48.3 ± 12.1) | Manipulation, 3 days each week, for 4 weeks | VAS, ODI, effective rate |
Lin HR 2018 | LDH (10.50 ± 8.41/9.97 ± 8.11) | Baduanjin (八段锦) (20D) | 57, T: 2- reason not reported C-1, reason not reported | 30 (16-12) / (40.44 ± 9.53) | Baduanjin, 2 times every 2 days, 2 times each practice, for 20 days + manipulation, 30 min each time, 1 time every 2 days, for 20 days | 30 (17-12) / (40.60 ± 7.21) | Manipulation, 30 min each time, 1 time every 2 days, for 20 days | VAS, effective rate |
Liu DZ 2018 | Cervical spondylotic radiculopathy (unclear) | Taiji (太极) (16W) | 60, no drop off reported | 30 (16-14) / (50.3 ± 6.5) | Taiji, QD, 60 min each time, 4 times each week, foe 16 weeks + Celebrex, QD, for 16 weeks + “米” shaped neck exercise, for 16 weeks | 30 (15-15) / (51.2 ± 7.1) | Celebrex, QD, for 16 weeks + “米” shaped neck exercise, for 16 weeks | VAS, Cervical motion range, Lovett score |
Pang H 2013 | LDH (T: 5.59 ± 3.29M/C: 6.02 ± 2.78) | Baduanjin (八段锦) (8W) | 64, no drop off reported | 32 (12-20) / (46.33 ± 9.46) | Baduanjin, QD, 30 min each time, for 8 weeks | 32 (14-18) / (47.25±8.43) | Manipulation, QD, 30 min each time, for 8 weeks | VAS, JOA |
Pan ZQ 2017 | Trigeminal neuralgia | Mind regulating acupuncture (4W) | 61, 2- adverse events caused by carbamazepine; 1- afraid of acupuncture | 33 (13-18) / (54 ± 11) | Mind regulating acupuncture, QD, 30 min each time, 6 days each week, for 4 weeks + Carbamazepine, 400-800 mg, BID, for 4 weeks | 32 (12-18) / (59 ± 11) | Carbamazepine, 400-800 mg, BID, for 4 weeks | Effective rate, VAS(+), pain occurrence rate, SF-36, 6-month follow up (VAS, pain occurrence rate, SF-36) |
Qiao HZ 2019 | Central post-stroke pain | Mind regulating and pain suppression acupuncture (4W, 8W) | 80, no drop off reported | 40, (24-16) / (70.09 ± 6.87) | Mind regulating and pain suppression acupuncture, BID, for 8 weeks + Gabapentin capsule, 0.1 g, TID, for 8 weeks + pregabalin capsule, 75 mg, BID, for 8 weeks + TENS, for 4 weeks | 40, (23-17) / (70.41 ± 6.98) | Gabapentin capsule, 0.1 g, TID, for 8 weeks + pregabalin capsule, 75 mg, BID, for 8 weeks + TENS, for 4 weeks | VAS, PSQI, S100β, NSE, effective rate, safety |
Shang QQ 2014 | LDH (unclear) | Baduanjin (八段锦) (Not reported) | 60, no drop off reported | 30, (unclear) / (unclear) | Baduanjin + manipulation | 30, (unclear) / (unclear) | Manipulation | VAS, JOA |
Song H 2006 | LDH (T: 12.71 ± 9.66M/C: 12.94 ± 8.22M) | Taiji (太极) (6M) | 68, no drop off reported | 37 (22-15) / (42.69 ± 15.38) | Taiji, 60 min each time, for 6 months + usual care | 31 (19-12) / (40.72 ± 13.10) | Usual care, physiotherapy mainly | Vital capacity, heart rate, systolic blood pressure, systolic blood pressure, sit and reach length, weight, straight leg raising test angle, VAS, JOA score, effective rate, nervus peroneus communis conduction rate, superficial peroneal nerve conduction rate |
Weng BQ 2021 | LDH (unclear) | Wuqinxi (五禽戏) (4W) | 62, T: 1- non adherence; C: 2- non adherence, 1- consumed other medicine | 33 (unclear) / (unclear) | Wuqinxi, BID, 5 min each time, for 4 weeks + manipulation, 1 time every 3 days, for 4 weeks | 33 (unclear) / (unclear) | Manipulation, 1 time every 3 days, for 4 weeks | VAS, JOA, muscle strength, effective rate, 2-month follow up (recurrence rate), safety |
Wang X 2019 | Central post-stroke pain | Mind regulating and pain suppression acupuncture (4W) | 123, no drop off reported | 62, (30-32) / (60.45 ± 8.13) | Mind regulating and pain suppression acupuncture, for 4 weeks + Antihypertensive agents + antiplatelet agents+ TENS, 20 min each time, for 4 weeks | 61, (32-29) / (59.69 ± 8.09) | Antihypertensive agents + antiplatelet agents+ TENS, 20 min each time, for 4 weeks | Effective rate, VAS, FMA, IL-6, TNF-α |
Xu H 2015 | LDH (T: 6. 93 ± 4. 06M/C: 6. 67 ± 3. 94 M) | Baduanjin (八段锦) (4W) | 16, no drop off reported | 8, (5-3) / (48.33 ± 11.25) | Baduanjin, BID, 30 min each time, for 4 weeks + chlorzoxazone, 2 pill, TID, for 4 weeks + diosmin, 2 pill, BID, for 4 weeks | 8, (4-4) / (47.87 ± 10.20) | Chlorzoxazone, 2 pill, TID, for 4 weeks + diosmin, 2 pill, BID, for 4 weeks | IL-1β, IL-6, TNF-α, VAS, JOA |
Xu XX 2018 | LDH (T: 24.33 ± 10.8 6M/C: 23.91 ± 10.16 M) | Baduanjin (八段锦) (4W, 8W, 12W) | 90, T: 2- non adherence; C: 2- non adherence | 45, (20-25) / (45.27 ± 4.24) | Baduanjin, 30 min each time, 5 times every week, for 12 weeks | 45, (21-24) / (44.71 ± 4.42) | Manipulation, BID, 30 min each time, for 22 days | VAS, SF-36 |
Yang LL 2019 | Cervical spondylotic radiculopathy (T: 3 to 42 M/C: 1 to 41 M) | Yijinjing (易筋经) (4W) | 68, no drop off reported | 34, (16-18) / (29-65) | Yijinjing, BID, 10 min each time, for 4 weeks + Nerve block, 0.2% lidocaine 10 ml plus triamcinolone 10 ml, 1 time every week, for 4 weeks | 34, (16-18) / (30- 65) | Nerve block, 0.2% lidocaine 10 ml plus triamcinolone 10 ml, 1 time every week, for 4 weeks | VAS, JOA, 3-month follow up (chordal arc distance of cervical spine) |
Yuan JL 2019 | Cervical spondylotic radiculopathy (T: 44.32 ± 58.92M/C: 38.93 ± 54.05M) | Baduanjin (八段锦) (2W, 12W) | 60, no drop off reported | 30, (7-23) / (67.53 ± 5.58) | Baduanjin, 40 min each time, 4-5 times every week, for 12 weeks + mecobalamine, 1 pill, TID, for 2 weeks + traction, QD, 15-20 min, for 2 weeks + electroacupuncture plus far infrared therapy, QD, 30 min each time, for 2 weeks + manipulation, QD, 20-30 min each time, for 2 weeks + TENS, QD, 20 min each time, for 2 weeks + ultrashort wave therapy, QD, 15 min, for 2 weeks | 30 (9-21) / (67.00±7.18) | Mecobalamine, 1 pill, TID, for 2 weeks + traction, QD, 15-20 min, for 2 weeks + electroacupuncture plus far infrared therapy, QD, 30 min each time, for 2 weeks + manipulation, QD, 20-30 min each time, for 2 weeks + TENS, QD, 20 min each time, for 2 weeks + ultrashort wave therapy, QD, 15 min, for 2 weeks | VAS, SAS, SDS, cervical spine function |
Zhang HZ 2020 | Cervical spondylotic radiculopathy (T: 2.58 ± 1.91 Y/C: 2.70 ± 1.76Y) | Mind regulating Du channel- unblocking (通督调神/tongdu tiaoshen) massage (4W) | 60, no drop off reported | 30, (13-17) / (55.07 ± 5.45) | Mind regulating Du channel- unblocking massage, QD, for 4 weeks + traction, QD, for 4 weeks | 30 (12-18) / (54.43 ± 6.97) | Deanxit, 1 pill, QD, for 4 weeks + traction, QD, for 4 weeks | Effective rate, HAMA, VAS, cervical symptom scale |
Zheng HL 2019 | LDH (T: 19.52 ± 16.24 M/C: 21.9 ± 22.03) | Qigong (气功) (12W) | 63, T: 1-non adherence; C: 1- non adherence | 31, (14-17) / (49.32±10.67) | Qigong relaxation training, QD, 20 min each time, for 12 weeks + Electropuncture, 2 times every week, for 12 weeks | 30, (9-21) / (45.1 ± 12.19) | Electropuncture, 2 times every week, for 12 weeks | Effective rate, VAS, CODI, SAS, SDS, BST, MF, 1-month follow up (VAS level) |
Quality Assessment of Methodology

Effectiveness and Safety
Outcomes and comparisons | Effect estimate [CI] (EST, I2) | p | OTP (sample size) | Study ID |
---|---|---|---|---|
TCM mind-body movement versus physiotherapy | ||||
Lumbar herniated disc | ||||
VAS score | MD: -0.10, [-0.61, 0.41] (0.38) | .70 | 2W (60) | Chen SQ 2014 |
MD: 0.04, [-0.07, 0.15] (0.71, 66%) | .48 | 4W (210) | Han BL 2015; Li JH 2020; Xu XX 2018 | |
MD: -0.57, [-0.77, -0.36] (5.36, 25%) | <.01 | 8W (154) | Pang H 2013; Xu XX 2018 | |
MD: -0.07, [-0.38, 0.24] (0.45) | .65 | 9W (60) | Li F 2017 | |
MD: -0.73, [-0.90, -0.56] (8.21) | <.01 | 12W (90) | Xu XX 2018; | |
VAS score (follow-up) | MD: -1.24, [-2.14, -0.34] (2.70) | <.01 | 3M (57) | Chen SQ 2014 |
MD: -0.05, [-0.50, 0.40] (0.22) | .83 | 5M (60) | Li F 2017 | |
JOA score | MD: 1.55, [0.64, 2.46] (3.34) | <.01 | 2W (60) | Chen SQ 2014 |
MD: 3.42, [0.94, 5.90] (2.71) | <.01 | 8W (64) | Pang H 2013 | |
ODI score | MD: 2.09, [-0.46, 4.64] (1.61, 56%) | .11 | 4W (120) | Li JH 2020; Han BL 2015 |
MD: 0.06, [-2.98, 3.10] (0.04) | .97 | 9W (60) | Li F 2017 | |
SF-36 score | MD: 1.15, [-0.03, 2.33] (1.91) | .06 | 4W (90) | Xu XX 2018 |
MD: 5.04, [3.76, 6.32] (7.70) | <.01 | 8W (90) | Xu XX 2018 | |
MD: 8.95, [7.76, 10.14] (14.73) | <.01 | 12W (90) | Xu XX 2018 | |
TCM mind-body movement + physiotherapy versus physiotherapy | ||||
Lumbar herniated disc | ||||
VAS score | MD: -1.02, [-1.12, -0.91] (18.47, 68%) | <.01 | 4W (180) | Han BL 2015; Ji T 2021; Li JH 2020; |
MD: -0.86, [-1.60, -0.12] (2.28) | .02 | 20D (57) | Lin HR 2018 | |
MD: -0.22, [-0.55, 0.11] (1.32) | .19 | 9W (60) | Li F 2017 | |
MD: -0.69, [-1.35, -0.03] (2.05) | .04 | 12W (61) | Zheng HL 2019 | |
MD: -0.88, [-1.48, -0.28] (2.89) | <.01 | 6M (68) | Song H 2006 | |
MD: -1.07, [-1.48, -0.66] (5.10) | <.01 | NR (60) | Shang QQ 2014 | |
VAS score (follow-up) | MD: -0.36, [-0.76, 0.04] (1.78) | .07 | 5M (60) | Li F 2017 |
JOA score | MD: 2.13, [0.22, 4.04] (2.18) | .03 | 4W (60) | Ji T 2021; |
MD: 1.70, [0.97, 2.43] (4.55) | <.01 | NR (60) | Shang QQ 2014 | |
MD: 6.96, [4.02, 9.90] (4.64) | <.01 | 6M (68) | Song H 2006 | |
ODI score | MD: 0.18, [-2.33, 2.68] (0.14, 91%) | .89 | 4W (120) | Li JH 2020; Han BL 2015 |
MD: -5.62, [-8.89, -2.35] (3.36) | <.01 | 9W (60) | Li F 2017 | |
MD: -4.63, [-9.73, 0.47] (1.78) | .07 | 12W (61) | Zheng HL 2019 | |
SAS score | MD: -3.70, [-7.21, -0.19] (2.06) | .04 | 12W (61) | Zheng HL 2019 |
SDS score | MD: -3.21, [-6.71, 0.29] (1.80) | .07 | 12W (61) | Zheng HL 2019 |
Cervical spondylotic radiculopath | ||||
VAS score | MD: -1.15, [-1.37, -0.94] (19.28, 95%) | <.01 | 4W (150) | Feng L 2017; Guo H 2020 |
MD: -1.33, [-1.53, -1.13] (13.32) | <.01 | 12W (60) | Guo H 2020 | |
NDI | MD: -4.08, [-4.40, -3.76] (25.22) | <.01 | 4W (60) | Guo H 2020 |
MD: -5.20, [-5.47, -4.93] (37.45) | <.01 | 12W (60) | Guo H 2020 | |
TCM mind-body movement + chlorzoxazone + diosmin versus chlorzoxazone + diosmin | ||||
Lumbar herniated disc | ||||
VAS score | MD: -0.46, [-1.42, 0.50] (0.94) | .35 | 4W (16) | Xu H 2015 |
JOA score | MD: 2.86, [1.40, 4.32] (3.84) | <.01 | 4W (16) | Xu H 2015 |
TCM mind-body movement + manipulation vs. Manipulation + neck exercise | ||||
Cervical spondylotic radiculopath | ||||
VAS score | MD: -0.90, [-1.41, -0.39] (3.45) | <.01 | 4W (86) | Feng L 2017 |
TCM mind-body movement + celebrex + neck exercise vs. celebrex + neck exercise | ||||
Cervical spondylotic radiculopath | ||||
VAS score | MD: -1.61, [-2.12, -1.10] (6.20) | <.01 | 16W (60) | Liu DZ 2018 |
Lovett scale score | MD: 0.87, [0.67, 1.07] (8.40) | <.01 | 16W (60) | Liu DZ 2018 |
Cervical motion range | MD: -0.43, [-0.55, -0.31] (7.08) | <.01 | 16W (60) | Liu DZ 2018 |
TCM mind-body movement + mecobalamine +physiotherapy vs. mecobalamine + physiotherapy | ||||
Cervical spondylotic radiculopath | ||||
VAS score | MD: 0.03, [-0.39, 0.45] (0.14) | .89 | 2W (60) | Yuan JL 2019 |
MD: -1.57, [-1.94, -1.20] (8.29) | <.01 | 12W (60) | Yuan JL 2019 | |
SAS score | MD: -2.07, [-5.79, 1.65] (1.09) | .28 | 2W (60) | Yuan JL 2019 |
MD: -9.11, [-13.75, -4.47] (3.85) | <.01 | 12W (60) | Yuan JL 2019 | |
SDS score | MD: -0.16, [-4.67, 4.35] (0.07) | .94 | 2W (60) | Yuan JL 2019 |
MD: -5.50, [-9.76, -1.24] (2.53) | .01 | 12W (60) | Yuan JL 2019 | |
Cervical spine function score | MD: 0.10, [-0.92, 1.12] (0.19) | .85 | 2W (60) | Yuan JL 2019 |
MD: 4.90, [4.07, 5.73] (11.55) | <.01 | 12W (60) | Yuan JL 2019 | |
TCM mind-body massage + traction vs. deanxit+ traction | ||||
Cervical spondylotic radiculopath | ||||
VAS score | MD: -10.67, [-14.27, -7.07] (5.82) | <.01 | 4W (60) | Zhang HZ 2020 |
HAMA score | MD: -1.43, [-1.88, -0.98] (6.23) | <.01 | 4W (60) | Zhang HZ 2020 |
TCM mind-body movement + nerve block v. nerve block | ||||
Cervical spondylotic radiculopath | ||||
VAS score | MD: -1.35, [-1.87, -0.83] (5.06) | <.01 | 4W (68) | Yang LL 2019 |
JOA score | MD: -6.46, [-6.93, -5.99] (26.75) | <.01 | 4W (68) | Yang LL 2019 |
Aroma massage vs. manipulation | ||||
Sympathetic cervical spondylosis | ||||
NRS | MD: -1.50, [-1.92, -1.08] (6.95) | <.01 | 12D (86) | Fu Y 2021 |
NID | MD: -1.00, [-2.06, 0.06] (1.85) | .06 | 12D (86) | Fu Y 2021 |
Mind-body acupuncture + carbamazepine vs. carbamazepine | ||||
Trigeminal neuralgia | ||||
VAS score | MD: -0.06, [-0.49, 0.37] (0.27) | .78 | 4W (61) | Pan ZQ 2017 |
Pain occurrence rate | MD: -1.93, [-2.94, -0.92] (3.74) | <.01 | 4W (61) | Pan ZQ 2017 |
SF-36 | MD: 19.05, [11.82, 26.28] (5.16) | <.01 | 4W (61) | Pan ZQ 2017 |
VAS score (follow-up) | MD: -1.89, [-2.34, -1.44] (8.28) | <.01 | 6M (61) | Pan ZQ 2017 |
Pain occurrence rate (follow-up) | MD: -1.15, [-2.44, 0.14] (1.74) | .08 | 6M (61) | Pan ZQ 2017 |
SF-36 (follow-up) | MD: 29.92, [22.96, 36.88] (8.43) | <.01 | 6M (61) | Pan ZQ 2017 |
Mind-body acupuncture + gabapentin + pregabalin + TENS vs. gabapentin + pregabalin + TENS | ||||
Central post-stroke pain | ||||
VAS score | MD: -1.43, [-1.75, -1.12] (8.88) | <.01 | 4W (80) | Qiao HZ 2019 |
MD: -1.42, [-1.62, -1.22] (13.93) | <.01 | 8W (80) | Qiao HZ 2019 | |
Mind-body acupuncture + antihypertensive + antiplatelet agents + TENS vs. antihypertensive + Antiplatelet agents + TENS | ||||
Central post-stroke pain | ||||
VAS score | MD: -1.31, [-1.70, -0.92] (6.50) | <.01 | 4W (123) | Wang X 2019 |
FMA | MD: 13.37, [9.47, 17.27] (6.72) | <.01 | 4W (123) | Wang X 2019 |
Pain Intensity
TCM mind-body movement versus physiotherapy
TCM mind-body movement versus physiotherapy
TCM mind-body movement + chlorzoxazone + diosmin vs. chlorzoxazone + diosmin
TCM mind-body movement + manipulation vs. Manipulation + neck exercise
TCM mind-body movement + celebrex + neck exercise vs. celebrex + neck exercise
TCM mind-body movement + mecobalamine + physiotherapy vs. mecobalamine + physiotherapy
TCM mind-body massage + traction vs. deanxit + traction
TCM mind-body movement + nerve block versus nerve block
Aroma massage vs. manipulation
Mind-body acupuncture + carbamazepine versus carbamazepine
Mind-body acupuncture + gabapentin + pregabalin + TENS versus gabapentin + pregabalin + TENS
Mind-body acupuncture + antihypertensive + antiplatelet agents + TENS versus antihypertensive + antiplatelet agents + TENS
Pain Occurrence Rate
Physical Functioning
TCM mind-body movement versus physiotherapy
TCM mind-body movement versus physiotherapy
TCM mind-body movement + chlorzoxazone + diosmin versus chlorzoxazone + diosmin
TCM mind-body movement + celebrex + neck exercise versus celebrex + neck exercise
TCM mind-body movement + mecobalamine +physiotherapy versus mecobalamine + physiotherapy
TCM mind-body movement + nerve block versus nerve block
Aroma massage versus manipulation
Mind-body acupuncture + antihypertensive + antiplatelet agents + TENS versus antihypertensive + antiplatelet agents + TENS
Emotion Functioning
TCM mind-body movement + physiotherapy versus physiotherapy
TCM mind-body movement + mecobalamine +physiotherapy versus mecobalamine + physiotherapy
TCM mind-body massage + traction versus deanxit + traction
Physical and Emotion Functioning
TCM mind-body movement versus physiotherapy
TCM mind-body movement versus physiotherapy
Safety
Discussion
Summary of Key Findings
Comparison with Previous Similar Studies and Reviews
- Han K.H.
- Cho K.H.
- Han C.
- Cui S.
- Lin L.
- Baek H.Y.
- Kim J.
Suggestions for Conducting Trials in the Future
- Dworkin R.H.
- Turk D.C.
- Farrar J.T.
- Haythornthwaite J.A.
- Jensen M.P.
- Katz N.P.
- Kerns R.D.
- Stucki G.
- Allen R.R.
- Bellamy N.
- Carr D.B.
- Chandler J.
- Cowan P.
- Dionne R.
- Galer B.S.
- Hertz S.
- Jadad A.R.
- Kramer L.D.
- Manning D.C.
- Immpact ...
Limitations
Conclusion
Acknowledgments
Appendix. Supplementary materials
References
- Clinical observation of 30 cases of lumbar disc herniation treated by lumbar guidance.Journal of Fujian University of Traditional Chinese Medicine. 2014; 24: 1-3
- Pregabalin for neuropathic pain in adults.Cochrane Database of Systematic Reviews. 2019; 1CD007076
- Tramadol for neuropathic pain in adults.Cochrane Database Systematic Reviews. 2017; 6CD003726
- Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.Pain. 2005; 113: 9-19
- Observation of clinical rehabilitation effect of Baduanjin on patients with cervical spondylopathy of radiculopathy.Chinese Manipulation & Rehabilitation Medicine. 2017; 8: 20-22
- Mind-body therapies from traditional Chinese medicine: Evidence map.Frontiers in Public Health. 2021; 10659075
- Aromatherapy for sympathetic cervical spondylosis: a randomized controlled study.Journal of Jiangxi University of Traditional Chinese Medicine. 2021; 33
- Mind-body therapies for opioid-treated pain: A systematic review and meta-analysis.JAMA Internal Medicine. 2020; 180: 91-105
- Active mind-body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease.Cochrane Database Systematic Reviews. 2018; 10CD012290
- Clinical Observation on Yijinjingtuotian Combined withThree-step Five-method tuina for Nerve Root Cervical Spondylopathy.Fujian University of Chinese Medicine, 2020 (Master's thesis)
- Clinical Research on Baduanjin Combined with Electrical Interference for the Treatment of Lumbar Disc Herniation.Shandong University of Chinese Medicine, 2015 (Master's thesis)
- The effectiveness and safety of acupuncture treatment on sciatica: A Systematic Review and Meta-Analysis.Complementary Therapies in Medicine. 2022; 71 (Advance online publication)102872https://doi.org/10.1016/j.ctim.2022.102872
Higgins, J.P.T. & Thomas, J. (Eds.) (2022). Cochrane handbook for systematic reviews of interventions (version 6.3). Retrieved April 2, 2022, from https://training.cochrane.org/handbook/current
- Clinical Research on Massage Manipulation Combined with Yijinjing for the Treatment of Lumbar Intervertebral Disc Herniation (Liver-Kidney Deficiency Type).(Master's thesis) Heilongjiang University of Chinese Medicine, 2021
- Acupuncture for neuropathic pain in adults.Cochrane Database Systematic Reviews. 2017; 12CD012057
- Traditional Chinese exercises on pain and disability in middle-aged and elderly patients with neck pain: A systematic review and meta-analysis of randomized controlled trials.Frontiers in Aging Neuroscience. 2022; 14912945
- Clinical observation on the treatment of lumbar disc herniation with five mimic-animal boxing combining meridian plucking manipulation and sling exercise therapy.Rheumatism and Arthritis. 2017; 6
- Clinical observation on lumbar disc herniation treated by spinal fine adjustment combined with daoyin therapy.China Journal of Traditional Chinese Medicine and Pharmacy. 2020; 35: 999-1001
- Clinical observation of massage combined with Baduanjin training to improve lumbar intervertebral disc herniation in rehabilitation period.Chinese Manipulation and Rehabilitation Medicine. 2018; 9: 39-41
- Effect observation of the application of simplified Chen's Taiji Exercise on cervical spondylosis.Yiyao Qianyan. 2018; 8: 36-38
- Acupuncture for chronic nonspecific low back pain.Cochrane Database of Systematic Reviews. 2020; 12CD013814
- Mind and body practices.2017 (Retrieved April 2, 2022, from)
National Institute for Health and Care Excellence (NICE). (2020). Neuropathic pain in adults: pharmacological management in non-specialist settings clinical guideline [CG173]. Retrieved April 2, 2022, from https://www.nice.org.uk/guidance/cg173/chapter/1-Recommendations .
National Institute for Health and Care Excellence (NICE). (2020). Low back pain and sciatica in over 16s: assessment and management NICE guideline [NG59]. Retrieved April 2, 2022, from https://www.nice.org.uk/guidance/NG59/chapter/Recommendations#non-invasive-treatments-for-low-back-pain-and-sciatica
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.BMJ. 2021; 372: n71
- Clinical study on mind-regulating acupuncture in treating primary trigeminal neuralgia.Shanghai Journal of Acupuncture and Moxibustion. 2017; 36
- Clinical study of Baduanjin promoting rehabilitation of lumbar intervertebral disc herniation.China Journal of Chinese Medicine. 2013; 28: 1241-1243
- Effect of acupuncture combined with repeated transcranial magnetic stimulation on central neuralgia after cerebral infarction.Journal of Shenyang Medical College. 2019; 21
- Burden of illness associated with peripheral and central neuropathic pain among adults seeking treatment in the United States: a patient-centered evaluation.Pain Medicine (Malden, Mass.). 2014; 15: 2105-2119
- Pain severity and the economic burden of neuropathic pain in the United States: BEAT Neuropathic Pain Observational Study.ClinicoEconomics and Outcomes Research. 2014; 6: 483-496
- The IASP classification of chronic pain for ICD-11: Chronic neuropathic pain.Pain. 2019; 160: 53-59
- Clinical study on the effect of practicing Baduanjin on prognosis of patients with lumbar intervertebral disc herniation.China & Foreign Medical Treatment. 2014; 9: 39-41
- A Study on Effect of Taijiquan on Lumbar Disc Protrusion.Suzhou University, 2006 (Master's thesis)
- Mind-body interventions for depressive symptoms in chronic pain: A systematic review of meta-analyses.Pain Physician. 2021; 24: 61-72
- Mind and body therapy for fibromyalgia.Cochrane Database Systematic Reviews. 2015; 2015CD001980
- Neuropathic pain in the general population: a systematic review of epidemiological studies.Pain. 2014; 155: 654-662
- Effect of acupuncture method of modulating and suppressing pain on recovery of motor dysfunction caused by central pain after stroke and serum levels of IL-6 and TNF-α.International Medicine and Health Guidance News. 2019; : 25
- Clinical Effect of Massage Combined with Wuqinxi on Lumbar Intervertebral Disc Herniation.Fujisn University of Chinese medicine, 2021 (Master's thesis)
- Gabapentin for chronic neuropathic pain in adults.Cochrane Database Systematic Reviews. 2017; 6CD007938
- Effects of Baduanjin exercise on serum interleukin-1 beta, interleukin-6,and tumor necrosis factor-alpha in patients with lumbar disc herniation.Hunan Journal of Traditional Chinese Medicine. 2015; 31 (+40): 16-17
- Effects of Baduanjin exercise combined with massage on low back pain and quality of life in patients with non-acute lumbar disc herniation.Journal of Traditional Chinese Orthopedics and Traumatology. 2018; 30: 18-22
- Observation on the effect of para-cervical nerve block combined with Yi Jin Jing on the treatment of radiculopathy of cervical spondylosis.Beijing Journal of Traditional Chinese Medicine. 2019; 38: 270-272
- Application of Baduan Jin exercise combined with routine rehabilitation therapy in rehabilitation of senile patients with cervical spondylopathy of radiculopathy.Journal of Traditional Chinese Orthopedics and Traumatology. 2019; 31 (+34): 25-30
- Clinical study on manipulation of dredging the governor vessel and regulating mentality massage in the intervention of nerve root type cervical spondylosis with anxiety state.Guangming Journal of Chinese Medicine. 2020; 35
- Clinical Observation on the Therapeutic Effect of Fang Song Gong on the Treatment of Lumbar Disc Herniation.Shanghai University of Chinese Medicine, 2019 (Master's thesis)
- Oxcarbazepine for neuropathic pain.Cochrane Database Systematic Reviews. 2017; 12CD007963
Article info
Publication history
Publication stage
In Press Corrected ProofIdentification
Copyright
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy